Member Exclusive Longer Read Interview

Epigenetic therapies: targeting the CoREST complex to treat melanoma

In this interview, Jay Kalin, Instructor at Harvard Medical School, summarizes recent research into the development of epigenetic therapies to target melanoma cells.

Go to the profile of RxNet
Jul 11, 2018

Please sign in or register for FREE

Register to RxNet

RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.